A real-world study assessing the efficacy and safety of switching from basal bolus insulin therapy to once daily iGlarLixi in people with type 2 diabetes mellitus: soli de-escalation. - Giorgino, Francesco; Taybani, Zoltán; Cheng, Alice; Tebaibia, Amar; Anaforoglu, İnan; Lauand, Felipe; Servera, Soraly; Li, Xuan; Fonseca, Vivian (Diabetes Research & Clinical Practice, 2025)